Cutaneous T-Cell Lymphoma in Adults

We diagnose cutaneous T-cell lymphoma, cancer of the white blood cells found in the skin, and provide personalized treatments based on the latest scientific research. Our oncologists, hematologists, and dermatologists work together to provide you with ongoing care and monitoring. Integrative medicine specialists, psycho-oncologists, and social workers are also available to provide the support you need while managing this condition.

Clinical Trials and Research Studies

Phase 1

A Phase 1 Study of TJ011133 Administered Alone or in Combination with Pembrolizumab or Rituximab in Subjects with Relapsed/Refractory Advanced Solid Tumors and Lymphoma

Learn More

Phase 2

Open-label Multicenter Phase 2 Study Evaluating the Efficacy & Safety of Daratumumab in Pediatric & Young Adult Subjects =1 & =30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Learn More

Phase 3

EA9161: A Randomized Phase III Study of the addition of Venetoclax to Ibrutinib and Obinutuzumab versus Ibrutinib and Obinutuzumab in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL)

Learn More

Phase 2

NCI-COG PEDIATRIC MATCH (MOLECULAR ANALYSIS FOR THERAPY CHOICE)-PHASE 2 SUBPROTOCOL OF OLAPARIB IN PATIENTS WITH TUMORS HARBORING DEFECTS IN DNA DAMAGE REPAIR GENES

Learn More